{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:05:53Z","timestamp":1788595553368,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,29]],"date-time":"2004-07-29T00:00:00Z","timestamp":1091059200000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>  <jats:bold>Corticosteroids and photochemotherapy, using a combination of psoralen and ultraviolet A (PUVA) exposure, are the most widely prescribed therapies for vitiligo. These treatments are not uniformly effective and many patients have inadequate responses. Calcipotriene has been shown to be effective in adults and children with psoriasis when used as monotherapy and in combination with corticosteroids and phototherapy. We hypothesized that since the mechanisms of action for calcipotriene and corticosteroids are different, patients may develop more repigmentation with a combination of the two agents, while decreasing the side effects from both agents.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>Twelve patients with vitiligo (average age 13.1 years) were advised to use topical corticosteroids in the morning and topical calcipotriene in the evening. Of the 12 patients, 83% responded to therapy, with an average of 95% repigmentation by body surface area. Four of the patients who responded had previously failed trials of topical corticosteroids alone. All of the patients in this group had repigmentation. Eyelid and facial skin responded best to this therapy. None of the patients had adverse reactions to the treatment. Our results show that topical calcipotriene in combination with corticosteroids can repigment vitiligo, even in those patients who were previous topical corticosteroid failures.<\/jats:bold> <\/jats:p>","DOI":"10.1111\/j.0736-8046.2004.21418.x","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T05:15:35Z","timestamp":1091164535000},"page":"495-498","source":"Crossref","is-referenced-by-count":45,"title":["Calcipotriene and Corticosteroid Combination Therapy for Vitiligo"],"prefix":"10.1111","volume":"21","author":[{"given":"Lisa B.","family":"Travis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette B.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,29]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70194-X"},{"key":"e_1_2_5_3_2","first-page":"S55","article-title":"Topical application of calcipotriene and corticosteroids: combination regimens","volume":"37","author":"Lebwohl M","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_4_2","first-page":"S59","article-title":"Calcipotriol\/calcipotriene (Dovonex\/Daivonex) in combination with phototherapy: a review","volume":"37","author":"Koo J","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70103-M"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90349-7"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2000.00024-3.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04381.x"},{"key":"e_1_2_5_9_2","first-page":"472","article-title":"Is the efficacy of psoralen plus ultraviolet A for vitiligo enhanced by concurrent topical calcipotriol? A placebo\u2010controlled double\u2010blind study","volume":"145","author":"Ermis O","year":"2001","journal-title":"Br Med J"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.112357"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017991"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1999.00083.x"},{"key":"e_1_2_5_13_2","first-page":"169","volume-title":"Vitamin D in dermatology.","author":"Kissmeyer A\u2010M","year":"2000"},{"key":"e_1_2_5_14_2","first-page":"S42","article-title":"Vitamin D: a calciotropic hormone regulating calcium\u2010induced keratinocyte differentiation","volume":"37","author":"Bilke DD","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70320-7"},{"key":"e_1_2_5_16_2","first-page":"143","volume-title":"Vitamin D in dermatology.","author":"Dam TN","year":"2000"},{"key":"e_1_2_5_17_2","first-page":"133","volume-title":"Vitamin D in dermatology.","author":"Skov L","year":"2000"},{"key":"e_1_2_5_18_2","first-page":"67","volume-title":"Immunology.","author":"Roitt I","year":"2001"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114594"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12462072"},{"key":"e_1_2_5_21_2","first-page":"1474","article-title":"Regulation of melanin synthesis of B16 melanoma cells by 1\u03b1,25\u2010dihydroxyvitamin D3 and retinoic acid","volume":"45","author":"Hosoi J","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12462151"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02505036","article-title":"Defective calcium transport in vitiliginous melanocytes","volume":"228","author":"Schallreuter KU","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00456842"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/0001555575307309","article-title":"Hyperpigmentation due to calcipotriol (MC 903) plus heliotherapy in psoriatic patients","volume":"75","author":"Kokelji F","year":"1995","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02334.x"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0736-8046.2004.21418.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0736-8046.2004.21418.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:57:30Z","timestamp":1697140650000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0736-8046.2004.21418.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.0736-8046.2004.21418.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21418.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}